Breaking news

Private Healthcare Costs Reshape Global Migration Strategies For Wealthy Families

Global Wealth Migration And The Rising Cost Of Private Healthcare

In 2025, affluent families are witnessing a paradigm shift as global wealth migration collides with escalating disparities in private healthcare costs. For high-net-worth individuals, the true cost of reliable private care has become a decisive factor in selecting a place to live, invest, and secure residence or citizenship rights. This development is prompting a more nuanced consideration of long-term affordability, far beyond traditional metrics.

Record Demand And Emerging Priorities

Data from Henley & Partners, a global authority on residence and citizenship planning, reveals that the firm has received applications from 92 nationalities in 2025, across more than 50 residence and citizenship programs. Over the past five years, the firm has catered to clients from 136 nationalities. A 43% surge in applications comparing the first three quarters of 2024 to the same period in 2025 underscores the intensifying trend of cross-border mobility among the global elite.

Private Healthcare Costs As A Decisive Metric

Henley & Partners Chairman, Dr. Christian H. Kaelin, emphasizes that global mobility is now integral to risk management strategies for wealthy families. Beyond residence and citizenship, discerning private healthcare costs are playing a fundamental role in destination selection. The newly published SIP Health Cost Index 2025 serves as a systematic benchmark, detailing the true expenses of private healthcare based on International Private Medical Insurance premiums in 50 key countries.

Shifts In Healthcare Costs And Emerging Markets

The SIP Health Cost Index confirms expectations with familiar high-cost leaders such as the United States, which tops the list with average annual costs of USD 17,969 per person, followed by Hong Kong (USD 16,175) and Singapore (USD 14,231). However, emerging economies in Asia—such as China, Thailand, and Taiwan—are now entering the high-cost league. These markets are experiencing sharp increases in inpatient services, even as routine outpatient care remains affordable, posing unexpected challenges for families planning relocation.

Value Destinations And Strategic Implications

European markets illustrate a broad spectrum of private healthcare costs, with the United Kingdom, Greece, and Spain being among the priciest, partly due to additional regulatory costs like the Insurance Premium Tax. In contrast, Africa and most of Latin America remain relatively cost-effective, although Brazil’s premium market challenges this trend. In the Middle East, the United Arab Emirates has emerged as a significant player, driven by investments in high-end healthcare infrastructure.

Implications For Migrating Millionaires

The evolving landscape of private healthcare costs is now a critical input in cross-border planning for wealthy families. With the SIP Health Cost Index as a valuable tool, globally mobile families and their advisers are better equipped to anticipate long-term healthcare budgets and sidestep hidden costs, ensuring their relocation choices align with both lifestyle aspirations and financial prudence.

Conclusion

As global wealth migration intensifies, thoughtful analysis of private healthcare costs is essential for making informed decisions about residence and citizenship. This development reinforces the notion that in today’s interconnected world, the true price of quality healthcare can dictate the long-term viability of an international lifestyle.

Women Make Up A Majority Of The EU’s Science And Technology Workforce But The Real Gap Is Elsewhere

Women now make up the majority of the EU’s science and technology workforce. According to Eurostat, in 2025, more than 81.6 million people aged 15 to 74 were employed in science and technology occupations across the EU. Of those, 52.5% were women, equal to 42.8 million women. The number of women in these occupations rose by 27.9% compared with 2015, an increase of more than 9.3 million over a decade.

On the surface, the numbers resemble progress. However, Eurostat’s category requires context before that figure can be read accurately. The data refers to HRST, or Human Resources in Science and Technology, specifically people employed in science and technology occupations. These are roles where the main tasks require professional or technical knowledge in physical and life sciences, but also in social sciences and humanities. That definition is wider and broader than engineering, ICT, laboratory science, or high-tech research alone.

Zooming In

The gender picture changes once the data moves from a wider definition of the workforce to the narrower scientist-and-engineer (research and manufacturing) subgroup.

Scientists and engineers represented almost a quarter of all people employed in science and technology in the EU in 2025. Eurostat describes scientists and engineers as often being the innovators at the centre of technology-led development, making them an important subgroup to focus on separately.

Women accounted for only 40.8% of scientists and engineers in 2025, despite making up more than half of the wider category. That share has increased by a mere 0.5 percentage points over the past decade. The absolute number of women working as scientists and engineers rose from 5.3 million in 2015 to 8.2 million in 2025, despite the push from national and international organisations to increase the number of women in the field. Europe has expanded the number of women in science and technology occupations over ten years. However, that expansion has not extended equally into the scientist-and-engineer subgroup, where much of Europe’s research and innovation work is conducted.

In 2025, of the 39.4 million women aged 25 to 64 working in science and technology occupations in the EU, 35.5 million worked in service activities. Only 2.7 million worked in manufacturing. Women accounted for 57.5% of science and technology employment in services, but only 31.3% in manufacturing.

In 2025, the highest shares of women employed in science and technology occupations were recorded in Latvia at 62.4%, followed by Hungary’s Great Plain and North region at 61.1%, Estonia at 60.5%, Poland’s Central macroregion at 60.4%, and Lithuania at 60.3%. No EU country recorded a majority of women among science and technology workers in manufacturing.

Break-down

Eurostat’s figures measure employment in broad science and technology occupations. They do not show job security, pay levels, management roles, promotion rates, research leadership, or whether women are concentrated in junior or senior workplace positions.

The classification of “senior” also requires additional explanation. Eurostat reports that 45.9% of science and technology workers aged 25 to 64 in the EU were classified as “senior” HRST in 2025. In this dataset, “senior” refers to workers aged 45 to 64. It does not mean senior manager, senior researcher, team lead, or decision-maker.

A high female share in the wider Human Resource Science and Technology (HRST) category does not parallel equal representation across scientists, engineers, manufacturing roles, senior posts, pay, research funding, or decision-making. These figures also reflect the occupational mix inside each country or region, not only structural progress across all areas of science and technology.

The Case Of Cyprus

Eurostat data places Cyprus’s overall science and technology employment at 37.2% of the labour force in 2025, slightly above the EU-27 figure of 36.9%, and above Greece at 26.8%, Malta at 33.9%, and Turkey at 18.2%. This figure covers the total share of the labour force employed in science and technology across all genders.

Progress Or Work-in-Progress?

52.5% in the broad category. 40.8% among scientists and engineers. 31.3% in manufacturing. Europe’s gender gap in science and technology hasn’t closed yet, and there is still work to be done to encourage and support more women to enter the field, especially in research and manufacturing.

Let’s not wait another decade for another couple of percentage points of hope.

eCredo
Aretilaw firm
The Future Forbes Realty Global Properties
Uol

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter